| human | Q5 |
| P6178 | Dimensions author ID | 01360436762.35 |
| P496 | ORCID iD | 0000-0003-1845-9373 |
| P1053 | ResearcherID | G-9798-2012 |
| P1153 | Scopus author ID | 14825230800 |
| P69 | educated at | University of Southern California | Q4614 |
| Oregon Health & Science University | Q282097 | ||
| P108 | employer | UCLA David Geffen School of Medicine | Q842165 |
| Rowan University | Q1799872 | ||
| National Institute on Drug Abuse | Q6973751 | ||
| P735 | given name | Thomas | Q16428906 |
| Thomas | Q16428906 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q41444993 | A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus |
| Q37617118 | A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats |
| Q28828620 | Beyond small-molecule SAR: using the dopamine D3 receptor crystal structure to guide drug design |
| Q33768527 | Chiral Resolution and Serendipitous Fluorination Reaction for the Selective Dopamine D3 Receptor Antagonist BAK2-66 |
| Q93333645 | Discovery, Optimization and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist |
| Q64080830 | Dopamine D Receptor-Selective Compounds Reveal Structure-Activity Relationships that Engender Agonist Efficacy |
| Q44805749 | Dopamine D4 receptor deficiency in mice alters behavioral responses to anxiogenic stimuli and the psychostimulant methylphenidate. |
| Q34314041 | Fenobam sulfate inhibits cocaine-taking and cocaine-seeking behavior in rats: implications for addiction treatment in humans. |
| Q37077658 | High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout Mice. |
| Q40955120 | Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment. |
| Q90889342 | Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia |
| Q37025051 | Novel Analogues of (R)-5-(Methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Sumanirole) Provide Clues to Dopamine D2/D3 Receptor Agonist Selectivity |
| Q48252285 | Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D3 Receptor (D3R). |
| Q47390221 | The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes |
| Q48145124 | Toward Understanding the Structural Basis of Partial Agonism at the Dopamine D3 Receptor |
| Q34435684 | Tranylcypromine substituted cis-hydroxycyclobutylnaphthamides as potent and selective dopamine D₃ receptor antagonists. |
| Q35554948 | Using click chemistry toward novel 1,2,3-triazole-linked dopamine D3 receptor ligands |
Search more.